The alarming rate of obesity and weight gain in industrialized nations is one of the most concerning health issues plaguing developed countries today. Scientists might have just come much closer to finally ending this epidemic by preventing mice from gaining weight even with a steady diet of high-fat food. Could these findings lead to effortless weight loss?
Published on eLife, the study described how scientists from Washington University School of Medicine basically activated certain pathways in fat cells, which essentially allowed the mice to go on a high-fat diet without becoming obese. This could lead to some huge leaps in treating all the other diseases that are associated with weight gain, including type-2 diabetes.
“Here by inducing expression of constitutively active Smoothened (SmoM2) or Gli2 (ΔNGli2) in the adipocyte lineage of postnatal mice, we show that targeted activation of Hh signaling suppresses high-fat-diet-induced obesity and improves whole-body glucose tolerance and insulin sensitivity,” the study reads.
As senior investigator Fanxin Long, Ph.D. put it, these findings could lead to new ways to treat the growing obesity epidemic afflicting populations even in developing countries. It also makes preventing weight gain easier because it targets the root cause of the issue.
"This could lead us to a new therapeutic target for treating obesity," Long said. "What's particularly important is that the animals in our study ate a high-fat diet but didn't gain weight, and in people, too much fat in the diet is a common cause of obesity."
On that note, translating the results of this study to apply to humans might not be that easy, MedicalXpress reports. The test subjects and people don’t exactly have the same metabolism and the methods used to activate the pathways in fat cells to stop them from growing might cause unknown side-effects. It might even cause cancer if the application is not done properly.


Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
Trump Administration Releases New UFO Files and Apollo Mission Records
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
China vs. NASA: The New Moon Race and What's at Stake by 2030
Is dark chocolate healthier than milk chocolate? 2 dietitians explain
Tabletop particle accelerator could transform medicine and materials science
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand 



